Both Electromed Inc. (NYSEAMERICAN:ELMD) and Hancock Jaffe Laboratories Inc. (NASDAQ:HJLI) are Medical Appliances & Equipment companies, competing one another. We will contrast their dividends, analyst recommendations, profitability, risk, earnings and valuation, institutional ownership.
Earnings and Valuation
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Hancock Jaffe Laboratories Inc.||2||164.71||N/A||-1.11||0.00|
Table 1 shows top-line revenue, earnings per share and valuation of the two companies.
Table 2 shows Electromed Inc. and Hancock Jaffe Laboratories Inc.’s return on assets, net margins and return on equity.
|Net Margins||Return on Equity||Return on Assets|
|Hancock Jaffe Laboratories Inc.||0.00%||-399.9%||-240.7%|
The current Quick Ratio of Electromed Inc. is 6.6 while its Current Ratio is 7.4. Meanwhile, Hancock Jaffe Laboratories Inc. has a Current Ratio of 1.6 while its Quick Ratio is 1.6. Electromed Inc. is better positioned to pay off its short-term and long-term debts than Hancock Jaffe Laboratories Inc.
Insider and Institutional Ownership
Institutional investors held 32.4% of Electromed Inc. shares and 1.3% of Hancock Jaffe Laboratories Inc. shares. About 8.8% of Electromed Inc.’s share are held by insiders. Insiders Competitively, held 30% of Hancock Jaffe Laboratories Inc. shares.
In this table we provide the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.
|Performance (W)||Performance (M)||Performance (Q)||Performance (HY)||Performance (Y)||Performance (YTD)|
|Hancock Jaffe Laboratories Inc.||3.19%||11.44%||-52.94%||-37.78%||-57.58%||-24.07%|
For the past year Electromed Inc. has 4.72% stronger performance while Hancock Jaffe Laboratories Inc. has -24.07% weaker performance.
Electromed Inc. beats on 7 of the 8 factors Hancock Jaffe Laboratories Inc.
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products in the United States and internationally. The company offers SmartVest airway clearance system that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to patients with compromised pulmonary function; and SmartVest SQL System that provides advanced generator programmability and an enhanced pause feature with save, lock, and restore functionality. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers working in intensive care units; and Aerobika, an oscillating positive expiratory pressure device. The company offers its products for patients with chronic lung issues, including bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was founded in 1992 and is headquartered in New Prague, Minnesota.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.